Healthy volunteers test drug interaction – no cure, just data
NCT ID NCT07097831
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a new drug called HRS-1301 changes the way the body processes rosuvastatin, a common cholesterol-lowering medication. Sixteen healthy adults took both drugs so researchers could measure drug levels in the blood. The goal was purely to gather information, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215004, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can two experimental pills work together safely? a trial seeks answers
- Can a new pill tame high cholesterol? a phase 1 trial puts SAL0167 to the test
- Gut bacteria may tame pancreatitis — probiotic combo put to the test
- Fatty meals may trap vitamin e in the blood, study suggests
- Could vinegar and fasting fix prediabetes cholesterol?
- Could a monthly shot beat biweekly for lowering cholesterol?